Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Anagenex has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Anagenex's investors include Menlo Ventures, Khosla Ventures, Catalio Capital Management, Lux Capital, Air Street Capital.
Anagenex is headquartered in Lexington, United States.
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Anagenex is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anagenex — Funding & Investors." VCBacked, June 8, 2022, https://www.vcbacked.co/company/anagenex. Accessed August 14, 2026.
VCBacked. (2022). Anagenex — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/anagenex
{{cite web |title=Anagenex — Funding & Investors |url=https://www.vcbacked.co/company/anagenex |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated